HRES 1434 · 117th Congress
Reaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Public Health Service Act (42 U.S.C. 201 et seq.) (including regulations thereunder) with respect to State laws that inhibit access to or use of any reproductive health product.
This bill hasn't been enriched yet — fetch cosponsors, actions, subjects, titles, and summaries from Congress.gov.
Why?
Every bill carries a core record (title, sponsor, latest action) that Concord fetches up front. The detailed sections — cosponsors, action history, subjects, titles, and summaries — live behind separate Congress.gov endpoints, so they're fetched on demand rather than for all 50,000+ bills at once. Until a bill has been enriched, those sections stay empty.
Brief
Executive summary
AI-generated
No executive summary yet — generate one to distill the facts below into a few sentences.
- Sponsor
- Mondaire Jones
- Policy area
- Health
- Introduced
- 2022-10-14
- Chamber
- House
Status
2022-12-21 —
Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.
Coalition
0 cosponsors
(0 original)
0 actions on file
0 recorded votes
No CRS summary available for this bill.
Latest action
2022-12-21 — Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.
Summaries
Summaries not yet fetched.
Sponsor
Mondaire JonesCosponsors
Cosponsors not yet fetched.
Vote history
No votes recorded for this bill yet.
Action history
Action history not yet fetched.
Subjects
Subjects not yet fetched.
Titles
Titles not yet fetched.